Why the study?
What is the most cost-effective screening program for microalbuminuria in outpatients with type 2 diabetes?
What is the most cost-effective screening program for microalbuminuria in outpatients with type 2 diabetes?
Answers are grounded in this paper and cite their sources.
May support cost-effective microalbuminuria screening in type 2 diabetes outpatients; leaves open optimal specimen type and frequency without direct trials.
The presence of microalbuminuria is associated with an increased risk for developing nephropathy and cardiovascular diseases in both type 1 and type 2 diabetes (1,2,3). A proper pharmacological treatment can reduce urinary albumin excretion rate (AER) and prevent clinical nephropathy. Consequently, the screening for microalbuminuria should be an essential tool of the care for diabetic patients. Controversy still exists regarding the type of urine specimen to be used to evaluate microalbuminuria. AER determined in timed urine collections (24 h or overnight) is the most direct measure of urinary albumin excretion (4,5). However, due to the demand of the protocol and frequent imperfect patient adherence, the AER is not practical for epidemiological studies or clinical settings. For these reasons, the measurement of the albumin-to-creatinine ratio (ACR) in a random spot urine has became a widely accepted clinical tool for assessing urinary albumin excretion (6,7,8). Recently, several semiquantitative office tests for detecting abnormal albuminuria have been developed (9). The aim of our study was to identify the easiest and most cost-effective screening program for microalbuminuria in an outpatient clinic. We evaluated specificity, sensitivity, and positive (PPV) and negative (NPV) predictive values …
No takes yet. Share an insight, caveat, or question.
Lepore et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: